The fate of nanoparticle surface chemistry during reductive electrosynthesis in aprotic media
Nanoscale · 2025 · 17 (11) · 6804-6814
DOI: 10.1039/d4nr04135f ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Xenia V Medvedeva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Waterloo Institute for Nanotechnology University of Waterloo, Waterloo, Ontario N2L 3G1, Canada. aklinkova@uwaterloo.ca. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: University of Waterloo, Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation.
Abstract (Originalsprache)
Reductive electrochemical coupling of carbon dioxide with organic molecules in aprotic media is affected significantly by the surface chemistry of the electocatalyst.
Autor:innen und Institutionen
- Department of Chemistry and Waterloo Institute for Nanotechnology University of Waterloo, Waterloo, Ontario N2L 3G1, Canada. aklinkova@uwaterloo.ca.
Förderung
- University of Waterloo
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
- Ontario Research Foundation
Zitieren
APA
Medvedeva, X. V., Medvedev, J. J., Zhao, X., Smith, E., & Klinkova, A. (2025). The fate of nanoparticle surface chemistry during reductive electrosynthesis in aprotic media. Nanoscale, 17(11), 6804-6814. https://doi.org/10.1039/d4nr04135f
Vancouver
Medvedeva XV, Medvedev JJ, Zhao X, Smith E, Klinkova A. The fate of nanoparticle surface chemistry during reductive electrosynthesis in aprotic media. Nanoscale. 2025;17(11):6804-6814. doi:10.1039/d4nr04135f
BibTeX
@article{Medvedeva2025,
author = {Medvedeva, Xenia V and Medvedev, Jury J and Zhao, Xingya and Smith, Elena and Klinkova, Anna},
title = {The fate of nanoparticle surface chemistry during reductive electrosynthesis in aprotic media},
journal = {Nanoscale},
year = {2025},
volume = {17},
number = {11},
pages = {6804--6814},
doi = {10.1039/d4nr04135f}
}
EUVIMED